Non-invasive Electrical Spinal Cord Stimulation To Restore Upper Extremity Function in Multiple Sclerosis
RecruitingNCT06552611Phase: PHASE1Started 2024-08-08
Summary
Current disease-modifying therapies for multiple sclerosis (MS) aim to prevent the development of new lesions; unfortunately, no current FDA-approved therapies promote central nervous system (CNS) rep
Eligibility
Sex
ALL
Min Age
21 Years
Max Age
70 Years
Locations
University of WashingtonSeattle, Washington, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06552611